Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 4 September 2018 to Question 167276 on haemophilia: medical treatments, whether those savings have been reinvested in supporting the haemophilia community; and whether any savings in the devolved nations of the UK have accrued to (a) NHS England or (b) the devolved administrations.

The National Health Service achieves savings across all clinical services, and reinvests those savings within its overall expenditure limits set by parliament. The NHS does not usually ring fence funding for specific patient groups, but considers its funding responsibilities for all patients based on all sources of funding, including procurement savings. Savings from medicines used by the devolved administrations remain within those administrations.